Madrid hosts the Imperial Springs International Forum for the first time, a key global platform for dialogue with China

MADRID, Nov. 22, 2024 /PRNewswire/ — The Imperial Springs International Forum (ISIF), co-organised by Club de Madrid, will hold its ninth edition on 11–12 December in Madrid. This marks the first time the Forum is held outside China, highlighting ISIF’s commitment to broadening multilateral dialogue and fostering a more inclusive and cooperative global order. Under… Continue reading Madrid hosts the Imperial Springs International Forum for the first time, a key global platform for dialogue with China

Madrid hosts the Imperial Springs International Forum for the first time, a key global platform for dialogue with China

MADRID, Nov. 22, 2024 /PRNewswire/ — The Imperial Springs International Forum (ISIF), co-organised by Club de Madrid, will hold its ninth edition on 11–12 December in Madrid. This marks the first time the Forum is held outside China, highlighting ISIF’s commitment to broadening multilateral dialogue and fostering a more inclusive and cooperative global order. Under… Continue reading Madrid hosts the Imperial Springs International Forum for the first time, a key global platform for dialogue with China

Changes in Board and Committee Composition

SHANGHAI, Nov. 22, 2024 /PRNewswire/ — Lufax Holding Ltd (“Lufax” or the “Company”) (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced that (i) Mr. Gregory Dean Gibb has retired from his roles as an executive director and the co-chief executive officer of the Company to dedicate more… Continue reading Changes in Board and Committee Composition

Madrid ist zum ersten Mal Gastgeber des Imperial Springs International Forum, einer wichtigen globalen Plattform für den Dialog mit China

MADRID, 22. November 2024 /PRNewswire/ — Das Imperial Springs International Forum (ISIF), das vom Club de Madrid mitorganisiert wird, findet am 11. und 12. Dezember zum neunten Mal in Madrid statt. Dies ist das erste Mal, dass das Forum außerhalb Chinas stattfindet und unterstreicht das Engagement der ISIF für die Ausweitung des multilateralen Dialogs und… Continue reading Madrid ist zum ersten Mal Gastgeber des Imperial Springs International Forum, einer wichtigen globalen Plattform für den Dialog mit China

Arctech Inaugurates New European Headquarters in Madrid, Paving the Way for a Grand European Expansion

MADRID, Nov. 22, 2024 /PRNewswire/ — Arctech, the world’s leading solar tracking and racking solutions provider, celebrated the relocation of its European headquarters in Madrid, Spain, on November 18th with a ribbon cutting ceremony. The event was attended by Chairman and President Cai Hao, General Manager of EU market, Pedro Magalhaes, and other distinguished guests.… Continue reading Arctech Inaugurates New European Headquarters in Madrid, Paving the Way for a Grand European Expansion

China Matters’ Feature: How High-Quality Development Is Shaping China’s Future

BEIJING, Nov. 22, 2024 /PRNewswire/ — China has entered a transformative phase in its economic evolution, prioritizing sustainability and innovation over rapid growth. This strategic shift, known as high-quality development, represents a fundamental change aimed at ensuring long-term prosperity while addressing global challenges. Continue Reading China Matters’ Feature: How High-Quality Development Is Shaping China’s Future… Continue reading China Matters’ Feature: How High-Quality Development Is Shaping China’s Future

FUTURE FUND OMAN LAUNCHES FIRST WAVE OF INVESTMENT PROJECTS WORTH OVER US$ 2 BILLION

MUSCAT, Oman, Nov. 22, 2024 /PRNewswire/ — Future Fund Oman (FFO), the latest investment initiative under Oman Investment Authority (OIA), has announced its first batch of approved investment projects. With a combined value exceeding US$ 2 billion, these projects include US$ 1.6 billion committed by foreign investors and US$ 571 million contributed by FFO. The… Continue reading FUTURE FUND OMAN LAUNCHES FIRST WAVE OF INVESTMENT PROJECTS WORTH OVER US$ 2 BILLION

@niche: Workhorse Group’s Financial Struggles Threaten Operations Amid Capital Shortage003640

https://www.tipranks.com/news/company-announcements/workhorse-groups-financial-struggles-threaten-operations-amid-capital-shortage Workhorse Group (WKHS) has disclosed a new risk, in the Debt & Financing category. Workhorse Group faces substantial business risk due to its inability to generate or secure additional capital, which is crucial for meeting current and future customer demands and expanding operations. The company’s persistent negative cash flow from operating activities, reported at… Continue reading @niche: Workhorse Group’s Financial Struggles Threaten Operations Amid Capital Shortage003640

Arctech Inaugurates New European Headquarters in Madrid, Paving the Way for a Grand European Expansion

MADRID, Nov. 22, 2024 /PRNewswire/ — Arctech, the world’s leading solar tracking and racking solutions provider, celebrated the relocation of its European headquarters in Madrid, Spain, on November 18th with a ribbon cutting ceremony. The event was attended by Chairman and President Cai Hao, General Manager of EU market, Pedro Magalhaes, and other distinguished guests.… Continue reading Arctech Inaugurates New European Headquarters in Madrid, Paving the Way for a Grand European Expansion

FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer

NANJING, China, Nov. 22, 2024 /PRNewswire/ — Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as “Leads Biolabs”) announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by the company with global intellectual property rights for the treatment of neuroendocrine cancer, has obtained Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA).… Continue reading FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer